Visalytics
Visalytics
approved EB-2 (NIW)

Scientist III, Research & Development

Pharmaceutical Sciences · India · 2024-05-17

Processing Time
132 days
Decision Date
2024-05-17
Location
North Carolina
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in pharmaceutical sciences, specifically focusing on advancing drug repurposing and the development of nanoparticle-based delivery systems. Her work aims to create smarter, more efficient ways to deliver medications for critical diseases such as cancer and COVID-19. This research is intended to provide faster, cost-effective pathways for translating laboratory discoveries into viable clinical treatments.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner's work in drug repurposing and nanoparticle delivery systems addresses critical national health priorities and reduces healthcare costs.

2 Well-positioned to Advance the Endeavor Met

Her record of 26 publications, 1,100+ citations, and 70+ peer reviews demonstrates her leadership and influence in the pharmaceutical field.

3 Balance of Factors Met

On balance, the U.S. benefits from waiving the labor certification due to the urgent need for her expertise in combating complex diseases.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 26 peer-reviewed journal articles, 16 conference abstracts, and 4 book chapters, which garnered over 1,100 citations. She also demonstrated her expertise by completing over 70 peer reviews for top-tier journals. The case was supported by independent expert letters and met the Dhanasar prongs by showing the national importance of her drug development strategies and her well-positioned status in the field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Assistant Professor

Pharmaceuticals · Syria

WeGreened EB-2 (NIW) approved
65 days 2022-03-23
The petitioner proposes to continue research in the development of new drug delivery carriers based on nanotechnology using a one-step reproducible process. This work focuses on developing DNA and RNA vaccines and treating diseases such as cancer, Alzheimer's, and diabetes. Additionally, the endeavor includes the development of new pediatric drugs designed to mask unpleasant tastes to ease ingestion for children.
View Case

Postdoctoral Researcher

Nanotechnology · Jordan

WeGreened EB-2 (NIW) approved
Maryland 90 days 2023-05-13
The petitioner proposes to improve the delivery of mRNA therapeutics to increase the effectiveness of gene therapies for incurable conditions. His work focuses on formulating and characterizing novel nanoparticles and developing advanced animal models to test therapeutics for brain diseases like Alzheimer's and anti-cancer drug delivery.
View Case

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 309 days 2025-04-01
The petitioner proposes to continue research in the United States focused on synthesizing tumor-targeted nanocarriers for RNA therapeutic delivery and improving mRNA purification systems. This work aims to develop cost-effective and scalable solutions for cancer vaccines and RNA-based therapies. The endeavor is designed to address critical challenges in cancer therapy and vaccine manufacturing.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
162 days 2025-04-17
The petitioner proposes to continue his research in molecular biomedicine, specifically focusing on the development of nanoparticle-based delivery systems. His work aims to improve targeted cancer therapies, including chemotherapy, immunotherapy, and tumor thermal therapy, to enhance therapeutic efficacy while reducing side effects. The intended impact is to advance cancer care and oncology breakthroughs within the U.S. healthcare system.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-05-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 132 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist